At the effective time of the merger all outstanding shares of Zila's common stock were converted into the right to receive USD0.45 per share in cash.
Zila is now a wholly-owned subsidiary of TOLMAR Holding, the holding company for Tolmar Inc, a pharmaceutical research, development, manufacturing and commercial operations company.
Zila is expected to continue its operations as a stand-alone business unit.
Its common stock ceased to be traded on Nasdaq as of Friday.
Comments on this story may be sent to admin@m2.com

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index